|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 491/048 | |
| A61K 31/4355 | |||
| A61P 3/04 | |||
| A61P 25/18 | |||
| A61P 25/22 | |||
| A61P 25/28 |
| (11) | Patento numeris | 2146997 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08742647.4 |
| Europos patento paraiškos padavimo data | 2008-04-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-01-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2010-11-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/004533 |
| Data | 2008-04-07 |
| (87) | Numeris | WO 2008/127585 |
| Data | 2008-10-23 |
| (30) | Numeris | Data | Šalis |
| 922851 P | 2007-04-11 | US |
| (72) |
CLEMENTS, Matthew, J., US
DEBENHAM, John, S., US
HALE, Jeffrey, J., US
MADSEN-DUGGAN, Christina, B., US
WALSH, Thomas, F., US
PERESYPKIN, Andrey, V., US
HELMY, Roy, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
|
| (54) | SUBSTITUTED FURO[2,3-B]PYRIDINE DERIVATIVES AS CANNABINOID-1 RECEPTOR MODULATORS |
| SUBSTITUTED FURO[2,3-B]PYRIDINE DERIVATIVES AS CANNABINOID-1 RECEPTOR MODULATORS |